The UK and the Trans-Pacific Partnership – Could patent conflicts ruin the deal?
Available in English and Japanese
Attention UK medical devices companies! The new enforcement rules for medical devices are (almost) here
A quick round-up of the key changes
by Alison Dennis and Justyna Ostrowska
The EU torpedoes itself in cross-border patent disputes
What the UK-EU Trade and Cooperation Agreement means for pharma and medical device companies
Placing medical devices on the UK market after the end of Brexit transition
Discussing incoming rules and MHRA guidance for placing medical devices on the market in Great Britain and Northern Ireland.
3 of 6 Insights
Targeted treatments – Part 4: patenting digital devices
Important advances are being driven by digital communications technology, particularly in the medical devices sector.
5 of 6 Insights
How to prepare for the MHRA's new medical devices enforcement rules
Key actions you can take to prepare for the new enforcement rules.
by multiple authors
1 of 6 Insights
Goodbye CE, hello UKCA
by Katie Chandler and Justyna Ostrowska
Brexit readiness for overseas medical devices manufacturers: trade marks
by multiple authors
Return to work: key issues for life sciences
by Helen Farr and Adrian Toutoungi
Private equity investment in life sciences sector
Exploring some of the potential benefits and challenges for life sciences companies considering PE investment.
by multiple authors
4 of 6 Insights
Licensing out: Try not to get benched
by Colin McCall and Justyna Ostrowska